Unusual symptoms found in cat scratch disease patients

Article

Vitreous haemorrhage with retinal vaculitis and isolated central retinal artery occlusion (CRAO) were reported in the eyes of patients with cat scratch disease

Vitreous haemorrhage with retinal vaculitis and isolated central retinal artery occlusion (CRAO) were reported in the eyes of patients with cat scratch disease (CSD), according to an investigation in International Ophthalmology.

CSD, caused by proteobacterium Bartonella henslae, has presented ocular complications including blurred vision and partial visual loss.

Dr Antonio Pinna et al., St Orsola-Malpighi University Hospital, Italy, investigated the cases of 2 CSD patients. One case involved a 42-year-old patient who had blurred vision for five days, with visual acuity in the right eye at 20/25. Fundus examination demonstrated mild vitreous haemorrhage, diffuse retinal haemorrhage and multiple vasculitic occlusions in the mid-peripheral retina. Immunoglobulin (Ig)M and IgG in B. henslae. Oral anzithromycin was administered for 8 days.

The second case involved a 66-year-old patient with systematic hypertension and hypercholerterolemia and reported visual loss in the left eye. Fluorescein angiography and fundus evaluation revealed CRAO and serologic testing confirmed the presence of IgM and IgG antibodies. The patient was given oral anzithromycin for 6 days.

One month after treatment the patient in case 1 had 20/20 vision in the right eye and the vitreous and retinal haemorrhages were resolved. The patient in case 2 had visual acuity in the left eye to the level of hand motion.

Ophthalmologists should always be aware of unusual ocular manifestations in CSD, especially vitreous haemorrhage with retinal vasculitis and isolated CRAO.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.